Study guide

6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload

Nursing and Midwifery Council of Ghana Licensing Examinations Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: N&MC Ghana Regulation, Licensing Pathway & Examination Format

1.1 Health Professions Regulatory Bodies Act, 2013 (Act 857) & the N&MC Mandate 1.2 Cadres, Indexing, Eligibility, Examination Windows & Fees 1.3 Registration, PIN vs. AIN, Rotation, Licence Renewal & Foreign-Trained Pathway 1.4 Examination Format: Computer-Based Papers, Practical Component, Results & Re-sits

2 Chapter 2: Professional Ethics, Law, Leadership & Patient Rights

2.1 N&MC Ghana Code of Conduct, Ethical Principles & Professional Boundaries 2.2 Ghana Health Service Patients' Charter, Informed Consent & Confidentiality 2.3 Clinical Documentation, Incident Reporting, Negligence & Legal Liability 2.4 Nursing Leadership, Ward Management, Handover & Team Communication

3 Chapter 3: Infection Prevention, Control & Healthcare Safety

3.1 Standard & Transmission-Based Precautions, Hand Hygiene & PPE 3.2 Sterilization, Decontamination & Healthcare Waste Management in Ghana 3.3 Injection Safety, Sharps Injury Prevention & Occupational Post-Exposure Prophylaxis

4 Chapter 4: Clinical Nursing Foundations, Nursing Process & Practical Skills

4.1 Vital Signs Assessment, Clinical Deterioration & Early Warning Scoring 4.2 Medication Administration, Dosages, High-Alert Drugs & Pharmacovigilance 4.3 Enteral & Parenteral Nutrition, Fluid and Electrolyte Balance & Acid-Base Disorders 4.4 Pain Assessment, Analgesic Ladder & Palliative Care in Ghana 4.5 Nursing Process, Care Plans, Care Study & the Practical Examination

5 Chapter 5: Respiratory, Cardiovascular & Neurological Nursing

5.1 Airway, Breathing & Oxygen Therapy: Asthma, COPD & Pneumonia 5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications 5.3 Hypertension Management, Hypertensive Emergencies & Stroke Care 5.4 Neurological Nursing: Unconscious Patient, Head Injury, Raised ICP & Epilepsy

6 Chapter 6: Endocrine, Renal, Gastrointestinal & Liver Disorders

6.1 Diabetes Mellitus, DKA, HHS & Glycemic Emergencies 6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload 6.3 Acute Abdomen, Peptic Ulcer Disease & Gastrointestinal Bleeding 6.4 Liver Disease (Hepatitis B, Cirrhosis, Hepatic Encephalopathy) & Thyroid Disorders

7 Chapter 7: Endemic Tropical Infections & Communicable Diseases

7.1 Malaria Management: Diagnostics, Uncomplicated & Severe Malaria Protocols 7.2 Tuberculosis Diagnosis, DOTS Protocol & Infection Control 7.3 HIV/AIDS Management, Antiretroviral Therapy (ART) & Opportunistic Infections 7.4 Enteric Infections: Cholera, Typhoid Fever & Diarrhoea Outbreak Response

8 Chapter 8: Hematology & Common Non-Communicable Conditions

8.1 Sickle Cell Disease: Vaso-Occlusive Crises, Anemia & Organ Protection 8.2 Blood Transfusion Practice, Crossmatching & Transfusion Reactions 8.3 Venous Thromboembolism, Anticoagulation & Pressure Injury Prevention

9 Chapter 9: Perioperative, Urological & Gynaecological Surgical Nursing

9.1 Preoperative Evaluation, Patient Preparation & Informed Consent 9.2 Intraoperative Care, Surgical Asepsis & WHO Surgical Safety Checklist 9.3 Postoperative Complications, Wound Healing & Dressing Techniques 9.4 Anesthesia Overview, Recovery Room (PACU) Care & Pain Management 9.5 Urological Surgical Nursing: Retention, BPH, Prostatectomy, Calculi & Catheter Care 9.6 Gynaecological Nursing: Ectopic Pregnancy, Abortion Care, Fibroids, PID & Cancer Screening

10 Chapter 10: Trauma, Burns & Acute Emergency Management

10.1 ABCDE Primary/Secondary Survey & Disaster Triage (START) 10.2 Major Burns: Rule of Nines, Parkland Fluid Resuscitation & Wound Care 10.3 Fractures, Immobilization, Compartment Syndrome & Spinal Precautions 10.4 Environmental Emergencies: Snakebites, Poisoning & Tetanus Prophylaxis

11 Chapter 11: Maternal Health, Obstetric & Postnatal Nursing

11.1 Antenatal Care (ANC/FANC), Risk Assessment & Health Promotion 11.2 Normal Labor, Stages & Partograph Monitoring 11.3 Obstetric Complications: Postpartum Hemorrhage (PPH) & Active Third Stage (AMTSL) 11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4 11.5 Postnatal Care, Breastfeeding Support & Family Planning

12 Chapter 12: Neonatal & Pediatric Nursing Care

12.1 Immediate Newborn Care, APGAR Scoring & Neonatal Resuscitation 12.2 Integrated Management of Neonatal & Childhood Illness (IMNCI) 12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

13 Chapter 13: Community Health Nursing & Primary Healthcare in Ghana

13.1 Community-Based Health Planning and Services (CHPS) Model 13.2 Disease Surveillance, Epidemic Preparedness & Community Health Education 13.3 Environmental Sanitation, Water Safety & School Health Services

14 Chapter 14: Mental Health Nursing & Psychiatric Care

14.1 Mental Health Act, 2012 (Act 846): Authority, Admission Routes & Rights 14.2 Common Psychiatric Disorders: Depression, Bipolar, Schizophrenia & Psychosis 14.3 Psychiatric Emergencies: Suicide Risk Assessment & De-escalation

6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload

Key Takeaways Explain This Topic AI

Acute Kidney Injury is categorized anatomically into prerenal (perfusion failure), intrinsic (parenchymal damage/ATN), and postrenal (urinary outflow obstruction) etiologies.

The clinical course of AKI progresses through oliguric (< 400 mL/24 hr, hyperkalemia, azotemia, fluid overload), diuretic (3-5 L/day, hypovolemia, hypokalemia), and recovery phases.

Chronic Kidney Disease is staged by eGFR, reaching Stage 5 / End-Stage Renal Disease when eGFR falls below 15 mL/min/1.73 m², producing systemic uremic manifestations.

Fluid restriction in oliguric renal failure is strictly calculated as the previous 24-hour total output plus 500 mL insensible fluid loss.

Arteriovenous (AV) fistula limb protection strictly mandates no venipuncture, IV lines, or blood pressure cuffs on the access extremity, with routine assessment of bruit and thrill.

Last updated: September 2026

6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload

Quick Answer: Renal failure represents the acute or chronic inability of the kidneys to excrete metabolic nitrogenous wastes, regulate fluid and electrolyte equilibrium, and maintain acid-base homeostasis. Acute Kidney Injury (AKI) is an abrupt decline in glomerular filtration rate (GFR) classified as prerenal (perfusion failure), intrinsic (tubular/parenchymal damage), or postrenal (mechanical urinary obstruction). Chronic Kidney Disease (CKD) represents progressive, irreversible structural nephron destruction staged from 1 to 5 based on eGFR, with Stage 5 ( < 15 mL/min/1.73 m 2 < 15\text{ mL/min/1.73 m}^2 < 15 mL/min/1.73 m 2 ) representing End-Stage Renal Disease (ESRD) requiring renal replacement therapy. Nursing management centers on strict fluid restriction, dietary protein and electrolyte modulation, and vascular access preservation.

Renal Physiology & Glomerular Filtration Dynamics

The kidneys maintain systemic homeostasis through continuous filtration, selective reabsorption, and active tubular secretion across approximately one million microscopic functional units termed nephrons in each kidney.

Glomerular Filtration: Blood enters the glomerular capillary tuft through the afferent arteriole under high hydrostatic pressure ( 55 mmHg ~55\text{ mmHg} 55 mmHg ). Water, electrolytes, glucose, amino acids, and nitrogenous wastes are forced across the glomerular filtration barrier into Bowman's capsule, forming the glomerular filtrate. Blood cells and large plasma proteins (such as albumin) are retained within the circulation.

Normal Glomerular Filtration Rate (GFR): Ranges between 90 – 120 mL/min/1.73 m 2 90\text{--}120\text{ mL/min/1.73 m}^2 90 – 120 mL/min/1.73 m 2 . A normal adult filters approximately 180 L 180\text{ L} 180 L of fluid daily, of which > 99 % > 99\% > 99% is reabsorbed along the proximal convoluted tubule, loop of Henle, distal convoluted tubule, and collecting ducts.

Urine Output Norms: Normal adult urine production is 1 – 2 mL/kg/hr 1\text{--}2\text{ mL/kg/hr} 1 – 2 mL/kg/hr (roughly 1500 mL/24 hr 1500\text{ mL/24 hr} 1500 mL/24 hr ). The absolute minimum physiological output required to clear obligatory metabolic nitrogenous solute loads without accumulating toxins is 0.5 mL/kg/hr 0.5\text{ mL/kg/hr} 0.5 mL/kg/hr (or 30 – 50 mL/hr 30\text{--}50\text{ mL/hr} 30 – 50 mL/hr ). Outputs below this threshold define oliguria.

Acute Kidney Injury (AKI): Etiologic Categories

Acute Kidney Injury is characterized by an abrupt (within 48 hours to 7 days) decline in renal function manifesting as elevated serum creatinine, increased blood urea nitrogen (BUN/azotemia), and variable reductions in urine volume. Etiologies are categorized into three distinct pathophysiological mechanisms: ACUTE KIDNEY INJURY (AKI)

  • |
  • +------------------------------+------------------------------+
  • | | |
  • PRERENAL INTRINSIC POSTRENAL
  • (Hypoperfusion) (Structural Damage) (Outflow Obstruction)
  • | | |
  • * Hypovolemia / Dehydration * Acute Tubular Necrosis * Prostatic Hyperplasia (BPH)
  • * Septic / Cardiogenic Shock - Ischemic insult * Bilateral Ureteral Calculi
  • * Severe Hemorrhage * Nephrotoxic Agents * Obstructing Bladder Masses
  • * Third-Spacing (Ascites) - Aminoglycosides * Blocked Urethral Catheter
  • * Excessive Diuretic Use - NSAIDs
  • IV Radiocontrast Dye
  • 1. Prerenal AKI (Renal Hypoperfusion)

Mechanism: Caused by conditions that reduce effective arterial blood flow and renal perfusion pressure without structural damage to the renal parenchyma. Glomerular capillary perfusion pressure drops, decreasing GFR.

Common Precipitating Causes: Severe hypovolemia from hemorrhage, gastrointestinal fluid loss (vomiting, cholera, severe diarrheal diseases common in tropical environments), systemic vasodilation in septic shock, congestive heart failure, and renal vasoconstriction.

Reversibility: Completely reversible if the underlying fluid or hemodynamic deficit is promptly corrected before prolonged ischemia causes secondary tubular necrosis.

2. Intrinsic / Intrarenal AKI (Parenchymal Damage)

Mechanism: Arises from direct structural or cytotoxic damage to the glomeruli, renal tubules, or interstitial tissue.

Acute Tubular Necrosis (ATN): Accounts for > 75 % > 75\% > 75% of intrinsic cases. ATN results from either prolonged, untreated prerenal ischemia or exposure to nephrotoxic agents.

Nephrotoxic Culprits:

Aminoglycoside antibiotics: Gentamicin, amikacin (accumulate within proximal tubular cells).

Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Indomethacin, ibuprofen (inhibit renal vasodilatory prostaglandins, precipitating medullary ischemia).

Radiographic Contrast Media: Iodinated dyes cause intense vasoconstriction and direct tubular injury.

Endogenous Toxins: Myoglobin from massive rhabdomyolysis (crush injuries, severe trauma, prolonged convulsions) and hemoglobin from massive hemolytic transfusion reactions.

3. Postrenal AKI (Mechanical Urinary Obstruction)

Mechanism: Mechanical obstruction of urinary flow anywhere from the renal pelvis down to the external urethral meatus. Retrograde pressure builds up within Bowman's capsule, counteracting glomerular filtration pressure.

Common Precipitating Causes: Benign prostatic hyperplasia (BPH) or prostate malignancy, bilateral ureteral calculi, retroperitoneal or cervical neoplasms, pelvic tumors, neurogenic bladder, or kinked/blocked indwelling Foley catheters.

Clinical Phases of Acute Kidney Injury

When intrinsic renal damage occurs, AKI characteristically evolves through three sequential clinical phases:

Phase Clinical Duration Pathophysiological Manifestations Critical Nursing Priorities

1. Oliguric / Anuric Phase 1 to 3 weeks (longer indicates poorer prognosis) Urine output < 400 mL/24 hr < 400\text{ mL/24 hr} < 400 mL/24 hr (anuria: < 50 – 100 mL/24 hr < 50\text{--}100\text{ mL/24 hr} < 50 – 100 mL/24 hr ). Rising serum creatinine and BUN (azotemia). Severe hyperkalemia (cardiac arrest risk), metabolic acidosis ( H + H^+ H + retention), hyperphosphatemia, hypocalcemia, hypervolemia (hypertension, peripheral edema, jugular venous distention, pulmonary edema). Enforce strict fluid restriction. Continuous ECG monitoring for hyperkalemic peaked T waves. Administer sodium polystyrene sulfonate or IV calcium gluconate/insulin-glucose. Daily weights.

2. Diuretic Phase 1 to 3 weeks Daily urine volume escalates dramatically ( 3 – 5 L/day 3\text{--}5\text{ L/day} 3 – 5 L/day ). Glomeruli filter blood, but recovering tubular epithelial cells cannot yet concentrate urine. BUN and creatinine plateau and gradually fall. Monitor for hypovolemic shock, severe dehydration, hypotension, hypokalemia, and hyponatremia. Fluid replacement matched to hourly urinary losses.

3. Recovery Phase 3 to 12 months Gradual normalization of GFR, tubular reabsorptive capacity, and serum electrolytes. Minor permanent reductions in GFR may persist. Prevent recurrent nephrotoxic insults. Reinforce outpatient follow-up and renal function monitoring.

Chronic Kidney Disease (CKD): Staging & Uremic Manifestations

Chronic Kidney Disease is defined as structural kidney damage or an eGFR < 60 mL/min/1.73 m 2 < 60\text{ mL/min/1.73 m}^2 < 60 mL/min/1.73 m 2 persisting for greater than 3 months . The Kidney Disease: Improving Global Outcomes (KDIGO) system classifies CKD into five stages:

Stage 1: Kidney damage with normal or elevated GFR ( eGFR ≥ 90 mL/min/1.73 m 2 \text{eGFR} \ge 90\text{ mL/min/1.73 m}^2 eGFR ≥ 90 mL/min/1.73 m 2 with persistent albuminuria or structural anomalies).

Stage 2: Mild reduction in GFR ( eGFR 60 – 89 mL/min/1.73 m 2 \text{eGFR } 60\text{--}89\text{ mL/min/1.73 m}^2 eGFR 60 – 89 mL/min/1.73 m 2 ).

Stage 3a & 3b: Moderate reduction in GFR (Stage 3a: 45 – 59 45\text{--}59 45 – 59 ; Stage 3b: 30 – 44 mL/min/1.73 m 2 30\text{--}44\text{ mL/min/1.73 m}^2 30 – 44 mL/min/1.73 m 2 ).

Stage 4: Severe reduction in GFR ( eGFR 15 – 29 mL/min/1.73 m 2 \text{eGFR } 15\text{--}29\text{ mL/min/1.73 m}^2 eGFR 15 – 29 mL/min/1.73 m 2 ; preparation for renal replacement therapy).

Stage 5: Kidney Failure / End-Stage Renal Disease (ESRD) ( eGFR < 15 mL/min/1.73 m 2 \text{eGFR} < 15\text{ mL/min/1.73 m}^2 eGFR < 15 mL/min/1.73 m 2 ; requires chronic hemodialysis, peritoneal dialysis, or kidney transplantation for survival).

Clinical Manifestations of Uremic Syndrome

When nitrogenous waste products accumulate systemically, uremic toxicity impacts every organ system:

Neurological: Uremic encephalopathy manifested by lethargy, mental sluggishness, confusion, tremors, asterixis ("flapping tremor" of dorsiflexed hands), peripheral neuropathy, and seizures.

Cardiovascular: Uremic pericarditis (distinguished by a harsh pericardial friction rub and positional chest pain), accelerated atherosclerosis, hypertension, and congestive heart failure from fluid overload.

Hematological: Normocytic normochromic anemia resulting primarily from deficient renal synthesis of erythropoietin (EPO) by peritubular capillary cells, shortened red blood cell lifespan in uremic plasma, and platelet dysfunction leading to bruising and mucosal bleeding.

Integumentary: Severe intractable pruritus, pale sallow/yellowish complexion (urochrome pigment deposits), and uremic frost (crystallized urea salts deposited on facial and skin surfaces due to extremely high blood urea).

Musculoskeletal / Mineral: Renal osteodystrophy (calcium/phosphate imbalance: hyperphosphatemia impairs vitamin D activation, driving secondary hyperparathyroidism and osteoclastic bone resorption).

  • Nursing Management of Fluid Overload & Dietary Modifications NURSING FLUID FORMULA IN OLIGURIA
  • +-----------------------------------------------------------------------------+
  • | Total 24-Hour Fluid Allowance = Previous 24-Hour Measured Output + 500 mL |
  • | (Urine + Emesis + Drainage) (Insensible Loss) |
  • +-----------------------------------------------------------------------------+
  • Fluid Restriction and Volume Assessment

In the oliguric phase of AKI or in Stage 5 CKD, fluid intake must be stringently regulated. The standard nursing fluid restriction formula is previous 24-hour total fluid output (urine, vomitus, drainage) plus 500 mL 500\text{ mL} 500 mL for insensible losses (evaporative loss from skin and expired air).

Daily body weight measurement is the single most sensitive indicator of fluid volume status. The nurse weighs the patient every morning at the exact same hour, using the same calibrated scale, wearing the same clothing, and following bladder voiding. A weight gain of 1 kg 1\text{ kg} 1 kg ( 2.2 lbs 2.2\text{ lbs} 2.2 lbs ) represents approximately 1000 mL 1000\text{ mL} 1000 mL ( 1 L 1\text{ L} 1 L ) of fluid retention .

Prescriptive Dietary Modifications

Sodium: Restricted to 2 – 3 g/day 2\text{--}3\text{ g/day} 2 – 3 g/day to minimize thirst, water retention, and severe hypertension.

Potassium: Strictly restricted ( < 2 g < 2\text{ g} < 2 g or < 50 – 60 mmol/day < 50\text{--}60\text{ mmol/day} < 50 – 60 mmol/day ). Educate patients to avoid high-potassium foods: bananas, plantains, oranges, tomatoes, avocados, and dark green leafy vegetables.

Phosphorus: Restrict dairy products, organ meats, nuts, and dark colas. Administer calcium-based phosphate binders (e.g., calcium carbonate, calcium acetate) with meals so they bind dietary phosphorus in the intestinal tract for fecal excretion.

Protein: Controlled intake of high-biological-value protein (eggs, poultry, fish) to provide essential amino acids without generating excessive urea nitrogen. (Patients on chronic hemodialysis require higher protein intake due to dialytic protein losses).

Renal Replacement Therapy: Hemodialysis & Peritoneal Dialysis

When medical management fails to control fluid overload, severe hyperkalemia, refractory metabolic acidosis, or uremic encephalopathy, renal replacement therapy (RRT) is initiated.

1. Hemodialysis & Arteriovenous (AV) Fistula Access Care

Vascular Access: An internal Arteriovenous (AV) Fistula (surgical anastomosis of an artery to a vein, typically the radial artery to the cephalic vein) is the gold standard access. Requires 2 to 3 months to mature ("arterialize") before cannulation.

Vascular Patency Assessment: The nurse must assess the fistula every 4 to 8 hours:

Palpate for a Thrill: A continuous vibrating or buzzing sensation felt over the vascular access site.

Auscultate for a Bruit: A loud, continuous swishing or rushing vascular murmur heard with the stethoscope diaphragm.

Strict Limb Protection Protocol: The nurse must post a prominent "Limb Alert" over the bed. Never measure blood pressure, perform venipuncture, insert an intravenous cannula, or place tight clothing/bands on the arm bearing the AV access. Compression induces thrombosis and renders the access unusable.

Dialysis Disequilibrium Syndrome (DDS): A neurological complication occurring during or shortly after rapid initial hemodialysis sessions. Urea is cleared rapidly from the vascular compartment while remaining trapped in brain tissue, creating an osmotic gradient that shifts fluid into cerebral cells. Manifestations include severe headache, nausea, vomiting, confusion, muscle twitching, seizures, and coma. Prevented by initiating hemodialysis slowly with reduced blood flow rates.

2. Peritoneal Dialysis (PD) & Peritonitis Recognition

Peritoneal dialysis utilizes the patient's peritoneal membrane as a semipermeable filter, instilling hypertonic dextrose dialysate via an indwelling Tenckhoff catheter.

Strict Asepsis: The connection of dialysate bags must be performed under scrupulous aseptic technique; both nurse and client must wear surgical masks to avoid airborne droplet contamination.

Peritonitis: The most dangerous complication of peritoneal dialysis. The earliest and most reliable hallmark sign is cloudy or turbid dialysate drainage effluent (effluent is normally crystal clear straw-colored). Associated signs include diffuse abdominal pain, rebound tenderness, fever, and dialysate effluent white blood cell count > 100 / μ L > 100/\mu\text{L} > 100/ μ L with > 50 % > 50\% > 50% neutrophils.

Nursing Action: Immediately notify the nephrology team, obtain dialysate effluent samples for microbiological culture and cell count, and prepare for intraperitoneal antibiotic instillation.